INVESTORS & MEDIA
Corporate Governance
| Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| Jul 01, 2016 |
Director, Chairman of the Board
Trans History: 742
|
Director, Chairman of the Board | Form 4 | Bona fide gift | 608 | -- | 152,356 |
| May 24, 2016 |
Director
Trans History: 524
|
Director | Form 4 | Bona fide gift | 1,000 | -- | 38,500 |
| May 16, 2016 |
SVP Clinical Development & Reg
Trans History: 208
|
SVP Clinical Development & Reg | Form 4 | Bona fide gift | 2,459 | -- | 2,459 |
| May 16, 2016 |
SVP Clinical Development & Reg
Trans History: 208
|
SVP Clinical Development & Reg | Form 4 | Bona fide gift | 2,459 | -- | -- |
| May 16, 2016 |
SVP Clinical Development & Reg
Trans History: 208
|
SVP Clinical Development & Reg | Form 4 | Bona fide gift | 2,459 | -- | 2,459 |
| May 16, 2016 |
SVP Clinical Development & Reg
Trans History: 208
|
SVP Clinical Development & Reg | Form 4 | Bona fide gift | 2,459 | -- | 2,459 |
| Apr 01, 2016 |
Director, Chairman of the Board
Trans History: 742
|
Director, Chairman of the Board | Form 4 | Bona fide gift | 584 | -- | 152,964 |
| Feb 26, 2016 |
Director
Trans History: 524
|
Director | Form 4 | Bona fide gift | 1,000 | -- | 40,500 |
| Feb 19, 2016 |
EVP Research and Development
Trans History: 660
|
EVP Research and Development | Form 4 | Bona fide gift | 1,500 | -- | 40,470 |
| Jan 04, 2016 |
Director, Chairman of the Board
Trans History: 742
|
Director, Chairman of the Board | Form 4 | Bona fide gift | 387 | -- | 153,548 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.